Onderneming Aerovate Therapeutics, Inc.
Aandelen
AVTE
US0080641071
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,62 USD | +1,63% | +0,34% | -8,88% |
Vakgebied
Aantal werknemers: 51
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Benjamin Dake
FOU | Founder | 48 | 27-07-18 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01-02-21 |
George Eldridge
DFI | Director of Finance/CFO | 61 | 01-03-21 |
Marco Verwijs
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-22 |
Hunter Gillies
CTO | Chief Tech/Sci/R&D Officer | 58 | 01-05-20 |
Ralph Niven
CTO | Chief Tech/Sci/R&D Officer | 64 | 01-07-20 |
Timothy Pigot
PRN | Corporate Officer/Principal | - | 01-06-21 |
Sue Fischer
PRN | Corporate Officer/Principal | - | - |
Donna Dea
LAW | General Counsel | - | 01-09-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Santel
BRD | Director/Board Member | 62 | 19-01-23 |
Maha Katabi
BRD | Director/Board Member | 50 | 01-08-20 |
Timothy Noyes
CEO | Chief Executive Officer | 62 | 01-02-21 |
Dave Grayzel
BRD | Director/Board Member | 56 | 01-08-20 |
Mark Iwicki
BRD | Director/Board Member | 57 | 01-02-21 |
Joshua Resnick
BRD | Director/Board Member | 49 | 01-10-18 |
Allison Dorval
BRD | Director/Board Member | 48 | 15-07-21 |
Habib Dable
CHM | Chairman | 54 | 10-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 737 381 | 28 728 904 ( 99,97 %) | 0 | 99,97 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,88% | 583 mln. | |
+22,81% | 47,9 mld. | |
+46,56% | 41,42 mld. | |
-1,88% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+11,33% | 25,55 mld. | |
-21,00% | 19,27 mld. | |
-1,43% | 12,15 mld. | |
+30,73% | 12,14 mld. | |
-0,48% | 11,99 mld. |
- Beurs
- Aandelen
- Koers AVTE
- Onderneming Aerovate Therapeutics, Inc.